Hasil Pencarian - Peter Schuld
- Menampilkan 1 - 3 hasil dari 3
-
1
PB1972: ASC4START: A PHASE IIIB, OPEN-LABEL, RANDOMIZED STUDY OF ASCIMINIB VERSUS NILOTINIB IN PATIENTS WITH NEWLY DIAGNOSED PH+ CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE oleh Andreas Hochhaus, Susanne Saussele, Francois-Xavier Mahon, Virginia Pilipovic, Yifan Zhang, Peter Schuld, Tim H Brümmendorf
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel -
2
P668: CHRONIC MYELOID LEUKEMIA SURVEY ON UNMET NEEDS (CML SUN): BALANCING TOLERABILITY AND EFFICACY GOALS OF PATIENTS AND PHYSICIANS THROUGH SHARED TREATMENT DECISION-MAKING oleh Fabian Lang, Zack Pemberton-Whiteley, Joannie Clements, Cristina Ruiz, Delphine Rea, Lisa Machado, Naoto Takahashi, Sung-Ho Moon, Andrew P Grigg, Cornelia Borowczak, Peter Schuld, Pauline Frank, Cristina Constantinescu, Carla Boquimpani, Jorge Cortes
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel -
3
High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients – final analysis of a randomized, multicenter, pha... oleh Andreas L. Petzer, Dominic Fong, Thomas Lion, Irina Dyagil, Zvenyslava Masliak, Andrija Bogdanovic, Laimonas Griskevicius, Sandra Lejniece, Stefan Goranov, Liana Gercheva, Aleksandar Stojanovic, Dontcho Peytchev, Nikolay Tzvetkov, Rasa Griniute, Atanas Stanchev, Thomas Grubinger, Marthin Kwakkelstein, Peter Schuld, Guenther Gastl, Dominik Wolf
Diterbitkan 2012-10-01Dapatkan teks lengkap
Artikel